Sensor skin for Liver Cirrhosis
Hunter Holmes McGuire VA Medical Center, Richmond, VA
Sensor skinN/ARecruitingLed by Jasmohan Bajaj, MDResearch Sponsored by Hunter Holmes Mcguire Veteran Affairs Medical CenterEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with frank decompensation (ascites, HE, variceal bleeding, hepato-pulmonary syndrome)
Patients with frank decompensation (ascites, HE, variceal bleeding, hepato-pulmonary syndrome)
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up3 days
Awards & highlights
No Placebo-Only Group
Study Summary
This trial found that measuring inflammation over time using a skin device was more predictive of disease outcomes than a single blood draw.
Eligible Conditions
- Liver Cirrhosis
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowSelect...
You have severe liver problems that are causing symptoms such as fluid buildup in the abdomen, confusion, bleeding from enlarged veins in the esophagus, or difficulty breathing due to liver-related lung issues.
Select...
You have severe liver problems that cause symptoms like fluid buildup in the abdomen, confusion, bleeding from veins in the esophagus, or lung problems related to the liver.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Therapeutic procedure
Secondary outcome measures
Interleukin-6
Interleukin-6
Linkage of inflammatory markers with MELD score
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Outpatients with cirrhosisExperimental Treatment1 Intervention
Outpatients with cirrhosis will receive the sensors
Group II: Inpatients with cirrhosisExperimental Treatment1 Intervention
Inpatients with cirrhosis will receive the sensors
Group III: Healthy controlsExperimental Treatment1 Intervention
Healthy controls will receive the sensors
Find a site
Who is running the clinical trial?
Hunter Holmes Mcguire Veteran Affairs Medical CenterLead Sponsor
31 Previous Clinical Trials
21,324 Total Patients Enrolled
7 Trials studying Liver Cirrhosis
245 Patients Enrolled for Liver Cirrhosis
Jasmohan Bajaj, MDPrincipal Investigator
Hunter Holmes McGuire VAMC3 Previous Clinical Trials
112 Total Patients Enrolled
2 Trials studying Liver Cirrhosis
64 Patients Enrolled for Liver Cirrhosis
Media Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are participants being sought after for this exploration?
"Yes, this investigation is actively recruiting. It was initially added to clinicaltrials.gov on September 1st of 2022 and updated most recently on the 9th of that same month. 60 patients need to be enrolled at a single facility for the trial's completion."
Answered by AI
How many individuals are participating in this experiment?
"Affirmative. Clinicaltrials.gov's information demonstrates that this investigation is recruiting participants, which began being posted on September 1st 2022 and was recently revised on the 9th of September 2022. The research team needs to find 60 people from a single clinical site."
Answered by AI
Who else is applying?
What site did they apply to?
Hunter Holmes McGuire VA Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0